Effect of seaweed-derived fucoidan on the glucose metabolism in patients with type 2 diabetes

Effect of seaweed-derived fucoidan on the glucose metabolism in patients with type 2 diabetes - Effect of fucoidan on T2D

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031171

Enrollment

Registered

2018-02-06

Start date

2015-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

fucoidan 12w -&gt

washout 4w -&gt

placebo 12w 1)a randomized, double-blind, placebo-controlled, cross-over study. The subjects received numbers in the order of giving informed consent, and subjects with odd numbers were assigned to

fucoidan 12w 1)a randomized, double-blind, placebo-controlled, cross-over study. The subjects received numbers in the order of giving informed consent, and subjects with odd numbers were assigned to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes attending the outpatient clinic of Hakuai Hospital, Japan who were on diet therapy only and who gave consent to the test.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
HbA1c and fasting plasma glucose before and after 12w interventions	—

Secondary

Measure	Time frame
Food intake by questionnaire, bowel movements and stool characteristics, and taste thresholds of 5 basic tastes (sweetness, saltiness, sourness, bitterness, and umami)	—

Countries

Japan

Contacts

Public ContactChieko Sakai

School of Health Sciences, Faculty of Medicine, Tottori University Department of Adult and Eldery Nursing

sakai@med.tottori-u.ac.jp0859-38-6317

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026